Toska Elona, Edun Olanrewaju, Zhou Siyanai, Leon Zea, Langwenya Nontokozo, Jochim Janina, Tolmay Janke, Sherman Gayle, Cluver Lucie Dale
Centre for Social Science Research, University of Cape Town Faculty of Humanities, Rondebosch, South Africa
Department of Social Policy and Intervention, University of Oxford, Oxford, UK.
BMJ Open. 2025 Jul 8;15(7):e092909. doi: 10.1136/bmjopen-2024-092909.
PURPOSE: Adolescents living with HIV (ALHIV) are a priority population for achieving global HIV prevention and treatment targets but experience poorer outcomes than adults. Long-term follow-up is essential to understand their transition into adulthood. By linking self-reported survey data with routine laboratory records, we established a social science clinical cohort of ALHIV South Africa's Eastern Cape to explore factors shaping their long-term health and well-being. PARTICIPANTS: Eligible participants were adolescents who were part of a three-wave quantitative cohort of ALHIV and not living with HIV (2014-2018) and had consented (adolescent and caregiver) to having their self-reported interviews linked with routine health records (n=1563). Adolescents were recruited into the existing three-wave cohort through clinic and community-based methods (97% enrolment, >90% retention over three waves). Between 2019 and 2022, we abstracted laboratory test records from the National Health Laboratory Services database for all eligible participants, with matching based on demographic variables. Individuals with at least one HIV-related record form our 'lifelong social science cohort', a total of 956 ALHIV (852 of 1107 ALHIV and 104 of 456 HIV-uninfected). FINDINGS TO DATE: A total of 32 886 laboratory test records from 2004 to 2023 were matched through three rounds of data extraction, using iteratively refined record-linking searches. Most records were viral load (8864) and CD4 count (6801) results, with a median of 10 (IQR: 7-14) and 8 (IQR: 5-11) tests per matched adolescent, respectively. Overall, 956 of 1563 adolescents (61%) were successfully linked to laboratory data, including 852 of 1107 (77%) ALHIV. Analysis of the matched cohort survey-laboratory data provided several insights. Self-reported antiretroviral therapy adherence was strongly associated with viral suppression, even after adjusting for covariates. The strongest predictors of suppression were not reporting missed doses in the past 3 days, past week and not missing clinic appointments in the past year. Among adolescent girls and young women living with HIV, access to safe and affordable facilities, and kind and respectful staff were associated with a higher likelihood of multiple improved HIV-related outcomes, including viral suppression. Exposure to sexual and intimate partner violence predicted worse viral load outcomes among adolescents. FUTURE PLANS: This integrated prospective cohort provides an opportunity to characterise long-term HIV treatment outcomes among ALHIV in Africa. We will investigate how individual, familial, community and healthcare experiences in childhood, and adolescence shape these outcomes. Since the COVID-19 pandemic happened during the period of matched data, we will also investigate the potential effect of the COVID-19 pandemic on adolescent HIV treatment outcomes, with potential subgroup analyses for individuals with available COVID-19-related results.
目的:感染艾滋病毒的青少年(ALHIV)是实现全球艾滋病毒预防和治疗目标的重点人群,但他们的治疗结果比成年人更差。长期随访对于了解他们向成年期的过渡至关重要。通过将自我报告的调查数据与常规实验室记录相联系,我们建立了一个南非东开普省ALHIV的社会科学临床队列,以探索影响他们长期健康和福祉的因素。 参与者:符合条件的参与者是参加了ALHIV三波定量队列且未感染艾滋病毒(2014 - 2018年)的青少年,他们(青少年及其照顾者)已同意将其自我报告的访谈与常规健康记录相联系(n = 1563)。青少年通过诊所和社区方法被纳入现有的三波队列(97%的入组率,三波中保留率>90%)。在2019年至2022年期间,我们从国家卫生实验室服务数据库中提取了所有符合条件参与者的实验室检测记录,并根据人口统计学变量进行匹配。至少有一份艾滋病毒相关记录的个体构成了我们的“终身社会科学队列”,共有956名ALHIV(1107名ALHIV中的852名以及456名未感染艾滋病毒者中的104名)。 迄今的研究结果:通过三轮数据提取,利用迭代优化的记录链接搜索,匹配了2004年至2023年的总共32886条实验室检测记录。大多数记录是病毒载量(8864条)和CD4细胞计数(6801条)结果,每个匹配的青少年的检测中位数分别为10次(四分位间距:7 - 14)和8次(四分位间距:5 - 11)。总体而言,1563名青少年中有956名(61%)成功与实验室数据相联系,其中包括1107名ALHIV中的852名(77%)。对匹配的队列调查 - 实验室数据的分析提供了一些见解。自我报告的抗逆转录病毒疗法依从性与病毒抑制密切相关,即使在调整协变量之后也是如此。抑制的最强预测因素是在过去3天、过去一周未报告漏服剂量以及在过去一年未错过诊所预约。在感染艾滋病毒的少女和年轻女性中,获得安全且负担得起的设施以及友善且尊重他人的工作人员与多种改善的艾滋病毒相关结果(包括病毒抑制)的更高可能性相关。遭受性暴力和亲密伴侣暴力预示着青少年中更差的病毒载量结果。 未来计划:这个综合的前瞻性队列提供了一个机会来描述非洲ALHIV的长期艾滋病毒治疗结果。我们将研究儿童期和青少年期的个人、家庭、社区及医疗保健经历如何影响这些结果。由于在匹配数据期间发生了新冠疫情,我们还将研究新冠疫情对青少年艾滋病毒治疗结果的潜在影响,并对有可用新冠相关结果的个体进行潜在的亚组分析。
Cochrane Database Syst Rev. 2010-3-17
Cochrane Database Syst Rev. 2011-12-7
J Int Assoc Provid AIDS Care. 2024
Cochrane Database Syst Rev. 2017-6-6
Psychiatry Clin Neurosci. 2022-11
Health Promot Int. 2022-6-23